Author

Abigail Johnston

Observed name: Abigail L. Johnston

Observed institutions: Duke University, HistoryMiami, Duke Medical Center, Duke Clinical Research Institute

OpenAlex ID: A5112408037

The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease

2016 · Abigail Johnston, W. Schuyler Jones, et al. · Current Cardiology Reports · 62

Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique

2024 · Emily J. Gallagher, Heather Moore, et al. · npj Breast Cancer · 37

Ankle-brachial index in patients with intermittent claudication is a poor indicator of patient-centered and clinician-based evaluations of functional status

2019 · Abigail L. Johnston, Sreekanth Vemulapalli, et al. · Journal of Vascular Surgery · 23

Systematic review and meta-analysis of endovascular and surgical revascularization for patients with chronic lower extremity venous insufficiency and varicose veins

2017 · Sreekanth Vemulapalli, Kishan Parikh, et al. · American Heart Journal · 21

Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD)

2017 · W. Schuyler Jones, Sreekanth Vemulapalli, et al. · Europe PMC (PubMed Central) · 6

Expert consensus recommendations for managing hyperglycemia and rash in patients with PIK3CA-mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) treated with alpelisib (ALP).

2022 · Emily J. Gallagher, Heather Moore, et al. · Journal of Clinical Oncology · 2

Real-world effectiveness of palbociclib plus hormone treatment and its impact on patient quality of life: a plain language summary of findings from POLARIS

2025 · Debu Tripathy, Joanne L. Blum, et al. · Future Oncology

EPIK-B4: A phase 2, randomized study of metformin (MET) extended release (XR) +/- dapagliflozin (DAPA) to prevent hyperglycemia (HG) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA-mutated (mut) advanced breast cancer (ABC) treated with alpelisib (ALP) and fulvestrant (FUL).

2022 · William John Gradishar, Azeez Farooki, et al. · Journal of Clinical Oncology

Abstract 18159: Association Between Ankle-Brachial Index Values, Symptom Classification, and PAD-Specific Health Status in Patients With Intermittent Claudication

2016 · Abigail Johnston, W. Schuyler Jones, et al. · Circulation

Works count: 9

Citation count: 151

H-index: 5

I10-index: 4